CymitQuimica logo

CAS 857086-93-2

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
  • (1S,2R)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol

    CAS :
    Formule :C32H31BrN2O2
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :555.5047

    Ref: IN-DA00G3QK

    1g
    À demander
    100mg
    À demander
    250mg
    À demander
  • (1S,2R)-Bedaquiline

    CAS :
    (1S,2R)-Bedaquiline
    Degré de pureté :98%
    Masse moléculaire :555.5g/mol

    Ref: 54-OR1033208

    100mg
    1.165,00€
    250mg
    1.719,00€
    1g
    3.156,00€
  • (1S,2R)-1-(6-BROMO-2-METHOXYQUINOLIN-3-YL)-4-(DIMETHYLAMINO)-2-(NAPHTHALEN-1-YL)-1-PHENYLBUTAN-2-OL

    CAS :
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :555.5159912109375

    Ref: 10-F824432

    10mg
    298,00€
    100mg
    883,00€
    250mg
    1.316,00€
    1g
    2.416,00€
  • (AlphaR,BetaS)-Bedaquiline

    Produit contrôlé
    CAS :

    Applications (αR,βS)-Bedaquiline is an intermediate in the synthesis of (αS,βR)-Bedaquiline (B119540), which is a diarylquinoline derivative that acts as a mycobacterial inhibitor. Bedaquiline shows promise as potential drug in the treatment of tuberculosis.
    References Cheepsattayakorn, A., et al.: Anti-Infect. Drug. Discover.,7, 141 (2012); de Jonge M.R. et al.: Proteins, 67, 971 (2007); Diacon A.H. et al.: N. Eng. J. Med., 360, 2397 (2009);

    Formule :C32H31BrN2O2
    Couleur et forme :Neat
    Masse moléculaire :555.5

    Ref: TR-B119535

    10mg
    290,00€
    25mg
    643,00€
    50mg
    1.217,00€
  • (AlphaR,BetaS)-Bedaquiline

    CAS :
    Formule :C32H31BrN2O2

    Ref: TR-TRC-B119535

    10mg
    À demander
    25mg
    À demander
    50mg
    1.184,00€
  • (±R,²S)-Bedaquiline

    CAS :

    (±R,²S)-Bedaquiline is a diarylquinoline that is used in the treatment of drug-resistant tuberculosis. It has shown efficacy against multidrug-resistant tuberculosis and has been shown to reverse abnormal changes in bacterial DNA induced by injury. Bedaquiline displays antimycobacterial activity and is typically used as part of a multidrug regimen for the treatment of tuberculosis. Clinical trials have demonstrated that bedaquiline can improve pulmonary function, reduce the risk of decline in lung function, and improve survival rates for patients with drug-resistant tuberculosis.

    Formule :C32H31BrN2O2
    Degré de pureté :Min. 95%
    Masse moléculaire :555.5 g/mol

    Ref: 3D-HJB08693

    25mg
    869,00€